Long-term safety of secukinumab in patients with moderate-to-severe plaque psoriasis, psoriatic arthritis, and ankylosing spondylitis: integrated pooled clinical trial and post-marketing surveillance data
2019 ◽
Vol 81
(4)
◽
pp. AB234
2015 ◽
Vol 43
(7)
◽
pp. 767-778
◽
Keyword(s):
Keyword(s):